UPDATED – Event: Workshop on the role of registries in the monitoring of cancer therapies based on genetic and molecular features (Amsterdam, 29 November 2019)

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

Agenda: Committee for Advanced Therapies (CAT) (4 – 6 December 2019)

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

Applications for new human medicines under evaluation by the Committee for Medicinal Products for Human Use

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

Instruction for the Applicants on how to follow the application status and next steps of the process updated

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

Agenda: Committee for Orphan Medicinal Products (COMP) (3 – 5 December 2019)

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

OPP Meeting Summary: EP ENVI Committee – Exchange of views with the Commission on the evaluation of the Union legislation on blood, tissues and cells (3 December 2019)

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

UPDATED – Agenda: EMA Paediatric Committee (PDCO) (25 – 28 June 2019)

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

UPDATED – Agenda: EMA Committee for Advanced Therapies (CAT) (6-8 November 2019)

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

Press Release: Meet the 10 EIC finalists who will pitch at the European Venture Contest

The European Innovation Council (EIC) pilot partnered with TechTour for five exclusive online pitching sessions on Healthtech, Digital Technologies and CleanTech. Between 11-13th November, 40 companies funded by the EIC Pilot participated in the TechTour ePitch, but only 10 winners were selected. The finalists will compete at the finals in the European Venture Contest in Essen, on the 9-10 December.

Press Release: State of Health in the EU: shift to prevention and primary care is the most important trend across countries

Today the European Commission published the reports that depict the profile of health systems in 30 countries. Country Health Profiles are being issued with the Companion Report that shows some of the biggest trends in the transformation of the healthcare systems and draws key conclusions from the Profiles.

UPDATED – Event: Regulatory Science to 2025 (stakeholders for human medicines) (Amsterdam, 18-19 November 2019)

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

Agenda: Pharmaceutical Committee (17 December 2019)

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

UPDATED – Comitology Written Consultation: Standing Committee on medicinal products for human use

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

Agenda: Coreper 1 Meeting (27 November 2019)

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

Presidency Note: European pharmaceutical policy – strengthened cooperation and coordination with the aim to improve access to medicines

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

Presidency Note: Economy of Wellbeing – next steps in investing in health as its key component

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

UPDATED – Agenda: EMA Committee for Advanced Therapies (CAT) (17-19 July 2019)

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

Comitology Written Consultation: Standing Committee on medicinal products for human use

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

UPDATED – Comitology Written Consultation: Standing Committee on medicinal products for human use

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

Comitology Written Consultation: Standing Committee on medicinal products for human use

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

Event: Future in Medicine – Innovative Cell and Gene Therapies, ATMP Workshop (Brussels, 3 December 2019)

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

Event: Forward together with innovation: The importance of policy making in the era of personalised medicine (Brussels, 3-4 December 2019)

The ​event ​will ​be ​held ​under ​the ​auspices ​of ​the ​Finnish ​Presidency ​of ​the ​EU, ​which ​will ​run ​from ​July ​to ​December. The ​Congress ​is ​in ​a ​focused ​format ​to ​allow ​concrete ​issues ​to ​be ​tackled ​and ​to ​have ​a ​dialogue ​with ​our ​policy ​makers. Essentially, ​this ​3rd ​annual ​Congress ​will ​provide ​the ​ideal ​space ​to ​allow ​for ​a ​meeting ​of ​minds ​and ​expertise ​and ​represent ​a ​vital ​opportunity ​for ​top-level ​discussion ​and the ​formulation ​of ​real ​action ​plans, ​for ​example ​in ​the ​area ​of ​translational ​research.
Congress ​will ​showcase ​different ​objectives ​which ​both ​the ​public ​and ​private ​sector ​can ​support, ​with ​a ​view ​to ​allowing ​the ​EU ​to ​present ​a ​common ​objective. Innovation ​and ​the ​incentives ​for ​it ​are ​key ​to ​health ​and ​wealth ​in ​the ​current ​EU-28 ​(and ​will ​be ​even ​more ​important ​after ​the ​UK ​leaves). It ​also ​encourages ​investment ​from ​outside ​of ​the ​EU, ​which ​is ​good ​for ​business ​and ​jobs. It ​is ​clear ​that ​innovation ​needs ​to ​soar ​to ​new ​heights, ​and ​be ​implemented ​and ​integrated, ​for ​the ​bene ​t ​of ​EU ​citizens.

Comitology Written Consultation: Standing Committee on medicinal products for human use

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

Comitology Written Consultation: Standing Committee on medicinal products for human use

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

Council Conclusions on European Court of Auditors’ Special Report No 07/2019: “EU actions for cross-border healthcare: significant ambitions but improved management required”

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. Cookies help you create your Policy Newsfeed for example. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close